Tower Research Capital LLC (Trc) Gossamer Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,456 shares of GOSS stock, worth $4,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,456
Previous 18,696 76.17%
Holding current value
$4,411
Previous $16,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.79 - $1.25 $11,249 - $17,800
-14,240 Reduced 76.17%
4,456 $4,000
Q2 2024

Aug 13, 2024
BUY
$0.51 - $1.27 $712 - $1,775
1,398 Added 8.08%
18,696 $16,000
Q1 2024

May 15, 2024
BUY
$0.8 - $1.51 $9,996 - $18,868
12,496 Added 260.22%
17,298 $20,000
Q4 2023

Feb 13, 2024
SELL
$0.48 - $1.08 $12,169 - $27,382
-25,354 Reduced 84.08%
4,802 $4,000
Q3 2023

Nov 14, 2023
BUY
$0.78 - $1.82 $6,484 - $15,129
8,313 Added 38.06%
30,156 $25,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $69,181 - $108,007
-70,593 Reduced 76.37%
21,843 $26,000
Q1 2023

May 09, 2023
BUY
$0.96 - $2.92 $22,606 - $68,760
23,548 Added 34.18%
92,436 $116,000
Q4 2022

Feb 10, 2023
BUY
$1.74 - $12.87 $92,394 - $683,397
53,100 Added 336.33%
68,888 $149,000
Q3 2022

Nov 10, 2022
BUY
$7.21 - $14.88 $92,662 - $191,237
12,852 Added 437.74%
15,788 $189,000
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $31,730 - $52,990
-5,315 Reduced 64.42%
2,936 $25,000
Q1 2022

May 12, 2022
BUY
$8.44 - $12.49 $45,576 - $67,446
5,400 Added 189.41%
8,251 $71,000
Q4 2021

Feb 14, 2022
SELL
$10.12 - $14.07 $47,027 - $65,383
-4,647 Reduced 61.98%
2,851 $32,000
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $10,396 - $18,971
-1,434 Reduced 16.05%
7,498 $94,000
Q2 2021

Aug 16, 2021
BUY
$8.0 - $9.75 $53,296 - $64,954
6,662 Added 293.48%
8,932 $72,000
Q1 2021

May 17, 2021
SELL
$8.63 - $10.94 $14,567 - $18,466
-1,688 Reduced 42.65%
2,270 $21,000
Q4 2020

Feb 16, 2021
BUY
$8.3 - $13.59 $14,325 - $23,456
1,726 Added 77.33%
3,958 $38,000
Q3 2020

Nov 16, 2020
SELL
$11.3 - $14.75 $63,133 - $82,408
-5,587 Reduced 71.45%
2,232 $28,000
Q2 2020

Aug 13, 2020
BUY
$9.52 - $15.98 $74,436 - $124,947
7,819 New
7,819 $102,000
Q1 2020

May 15, 2020
SELL
$8.0 - $15.48 $13,664 - $26,439
-1,708 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$14.82 - $26.79 $186,050 - $336,321
-12,554 Reduced 88.02%
1,708 $27,000
Q3 2019

Nov 05, 2019
BUY
$16.02 - $22.47 $228,477 - $320,467
14,262 New
14,262 $239,000
Q2 2019

Aug 13, 2019
SELL
$16.12 - $22.89 $1,902 - $2,701
-118 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$17.58 - $23.97 $2,074 - $2,828
118 New
118 $3,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email